FDA Looks to Make FOIA Process Easier
By Zachary Brennan, Regulatory Focus, Sept. 12, 2018
The US Food and Drug Administration (FDA) on Wednesday proposed a new rulemaking that would ease the process by which the public can use the Freedom of Information Act (FOIA) to request certain non-public information.
In addition to easing the process by which materials can be requested, the proposed rule will require FDA to establish procedures for identifying records of general interest or use to the public that are appropriate for public disclosure, and for posting such records in a publicly accessible electronic format.
Records requested three or more times under FOIA also would be made public, according to the proposed rule.
Read more here.